Amphista Therapeutics
Amphista Therapeutics operates as a biopharmaceutical company.
Amphista Therapeutics has raised €6.7M across 1 funding round from 1 investor, most recently a Series A round in Jul 2020. Based in Motherwell, UK; active in Healthtech. Data as of 28 Oct 2026.
Motherwell, UKwww.amphista.com ↗
Total raised
€6.7M
€6,682,110
Funding rounds
1
Investors
1
distinct backers
Active since
2020-07
latest 2020-07
Funding by year
EUR raised per yearAmphista Therapeutics — funding by year — interactive chart.
Data table
| Amphista Therapeutics — funding by year | |
|---|---|
| 2020 | €6.7M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-04 | Series A | €6.7M | Advent Life Sciences | View deal → |